electroCore (ECOR) Revenue Growth (1y) (2018 - 2026)
electroCore (ECOR) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.08% |
| 10 | electroCore | 55,642.90 | -8.77 Mn | 8.36 Mn | 42.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.64% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | 32.58% |
| Jun 30, 2025 | 20.23% |
| Mar 31, 2025 | 23.44% |
| Dec 31, 2024 | 35.73% |
| Sep 30, 2024 | 45.39% |
| Jun 30, 2024 | 72.88% |
| Mar 31, 2024 | 95.79% |
| Dec 31, 2023 | 102.77% |
| Sep 30, 2023 | 128.14% |
| Jun 30, 2023 | 64.63% |
| Mar 31, 2023 | 46.39% |
| Dec 31, 2022 | 71.70% |
| Sep 30, 2022 | 32.89% |
| Jun 30, 2022 | 69.98% |
| Mar 31, 2022 | 57.72% |
| Dec 31, 2021 | 60.62% |
| Sep 30, 2021 | 37.58% |
| Jun 30, 2021 | 68.54% |